Clinical Trials
🇪🇺 EMA Page 2EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 13–24 of 139 articles
Staff Stick: A B2B Guide to the Dual Meaning and Pharma Context
5 min
Dr. Elena RossiMyasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight — regulatory updates
myasthenia gravis · 4 min
Dr. Elena RossiNika Pharmaceuticals Inc OTCQB NIKA June 2026 Update: Key Developments and Strategic Implications
5 min
Dr. Elena RossiJapan Grants Orphan Status to QRX003 for Netherton Syndrome: Implications for Pharma Teams
MHLW · Netherton syndrome · 5 min
Dr. Elena RossiLilly to Spotlight Growing Hematology Portfolio at 2026 EHA Annual Meeting: Key Data and Strategic Implications
EMA · 6 min
Dr. Elena RossiBBIA Joins EuropaBio: Strengthening the Bio-Based Economy for Pharma and Industry
4 min
Dr. Elena RossiEMA, AMA and African Regulators Unite to Accelerate Ebola Clinical Trials
EMA · Ebola · 4 min
Dr. Elena RossiInsights from ESMO Asia: Nadia Harbeck on Oncology Advances
FDA · oncology · 4 min
Dr. Elena RossiKaléo's Initiative on Allergy Awareness: Amplifying Patient Stories
FDA · allergy · 5 min
Dr. Elena RossiEMA Horizon Scanning: Navigating Regulatory Updates for Future Medicines
FDA · 5 min
Dr. Elena RossiArrowhead Pharmaceuticals Presents Positive Cardiometabolic Data at European A Meeting
FDA · Cardiometabolic disorders · 6 min
Dr. Elena RossiFlorian Lordick Elected 2026 ESMO President: Implications for Global Oncology
FDA · oncology · 6 min
Dr. Elena Rossi